Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

Noticeboard: HIV-Infected Children


Lancet (06/13/92) Vol. 339, No. 8807, P. 1474

As it is difficult to ascertain the diagnosis and management of the HIV-positive child because of the lack of data from trials, some management policies will have to be estimated from findings in adults until trials in children are completed. Also, the difficulty in determining HIV serologic status in infants born to infected mothers makes the matter more complex. In children with HIV infection, Pneumocystis carinii pneumonia develops most commonly at age 3-6 months and carries a high mortality rate. It is advised by Dr. Diana Gibbs and Dr. Sam Walters that trimethoprim-sulphamethoxzole be administered to children of uncertain HIV-infection status from age 3 weeks. The doctors have devised guidelines addressing the management of HIV-infected children and related complications, and taking into account factors like regular childhood immunization, screening, confidentiality, and service issues. The guidelines will be routinely updated. Pediatricians who would like to get involved in the multicenter European clinical trials that evaluate treatments in HIV-positive children can receive details from Dr. Gibbs at the Institute of Child Health.


Copyright © 1992 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in June 13, 1992. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.